布魯克重組CAM擬出售GC、GCMS和ICPMS產品線

　　據外媒2014年7月23日消息，布魯克表示，它不相信其化學與應用市場部門(CAM)可以在未來兩年內實現“可接受的財務表現”，它計劃出售和或重組部分CAM業務，由此預期裁員200到250人。

　　在提交給美國證券交易委員會(SEC)的一份文件中，布魯克說，重組計劃將導致每年收入減少5000-7000萬美元，重組完成后，每年利潤預計可以增加1500-2000萬元美元。

　　重組CAM部門的決定已由布魯克董事會于7月18日批準，公司認為保留此業務已不再有意義。2010年，布魯克在收購了瓦里安部分業務后成立了CAM部門，并且從一開始，CAM就是布魯克財務的一個權重。在最近的一次投資者會議上，該公司負責人表示，布魯克將改革該部門。

　　在今天提交給SEC的文件中，布魯克列出重組CAM計劃的細節。它打算剝離或出售CAM的氣相產品線及相關服務，包括氣相系統和單四極桿氣質系統。布魯克說，至少一些資產的潛在銷售正在討論。

　　此外，布魯克擬出售或重組CAM的電感耦合等離子體質譜產品線(ICP-MS)及相關服務，并正在對這些資產的潛在銷售進行討論。但是，布魯克將保留CAM的三重四極桿氣質/液質產品線及相關服務，布魯克認為這部分業務在制藥、臨床和生命科學研究市場有增長的機會。

　　布魯克將從第三季度開始實施CAM重組計劃，重組預計到2015年6月30日前完成。

　　布魯克預計在2014下半年及2015年上半年CAM重組及其他一次性費用在3500-4000萬美元之間。布魯克還說，任何CAM相關業務出售的預期收益當前無法計算。

　　2013年，CAM部門的收入約1億美元。消息公布后，布魯克股票上漲了近3%，股價24.09美元。

　　附：布魯克公司關于此事告客戶信

　　Important customer information about ICP-MS, GC and GC-MS products

　　Dear Valued Bruker Customer,

　　After very careful analysis of our served markets and product portfolio, Bruker today announced the decision to reduce its Chemical & Applied Markets (CAM) Division product portfolio. Unfortunately, this decision became inevitable as CAM had generated significant losses for the last 4 years, and with its broad product and market scope there was no way to reach acceptable financial performance for CAM in the foreseeable future.

　　As a result of this decision, effective immediately, Bruker will stop selling its stand-alone GC systems and its single-quadrupole (SQ) GC-SQ mass spectrometry systems. Bruker will deliver and install our existing GC and GC-SQ order backlog, and we will continue to provide service and support for these products and there will be no change in customer service.

　　Bruker has also announced that it is seeking strategic buyers for its GC service business and separately for our ICP-MS business. If these businesses are divested to other global, analytical instrument companies, then further communications will be made to all customers.

　　Bruker will continue to develop, manufacture, sell and service our strategically important and successful EVOQ LC-MS and SCION GC-MS triple-quadruple (TQ) products as part of our Bruker Daltonics mass spectrometry product portfolio.

　　So what will this all mean to you?

　　We will continue to honor our service commitments for the GC and GC-SQ systems. Our GC systems service may be transferred to a potential other major analytical systems company before the end of 2014. We will retain GC-SQ service at Bruker.

　　We will deliver and install our GC and GC-SQ backlog during the second half of 2014, and we accept last-buy orders for GC and GC-SQ during the third quarter of 2014.

　　We will continue to invest vigorously in TQ-MS systems and their applied market applications. Our award-winning SCION GC-TQ and EVOQ LC-TQ systems will be retained by Bruker for sale by our commercial team and our approved distributors.

　　We will keep selling and supporting ICP-MS systems while we transition this business to a potential buyer. We expect to transfer our ICP-MS business to a global, high-quality analytical instruments company with a broader trace elemental analysis portfolio in the next few months.

　　This was a very difficult decision for Bruker and we will work hard with our valued customers to ensure minimization of any inconvenience caused by this decision and announcement.

　　Sincerely,

　　Elmar Illek

　　Senior Vice President

　　Bruker Daltonics Commercial Operations